Vice Provost and Dean of Research
Showing 51-60 of 1,760 Results
-
Laura Attardi
Catharine and Howard Avery Professor of the School of Medicine and Professor of Genetics
Current Research and Scholarly InterestsOur research is aimed at defining the pathways of p53-mediated apoptosis and tumor suppression, using a combination of biochemical, cell biological, and mouse genetic approaches. Our strategy is to start by generating hypotheses about p53 mechanisms of action using primary mouse embryo fibroblasts (MEFs), and then to test them using gene targeting technology in the mouse.
-
Christopher Wallace Austelle
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioChristopher Wallace Austelle, MD, is a board-certified psychiatrist and Clinical Assistant Professor investigating circuit-based treatments for mood and anxiety disorders. As a physician-scientist, he examines how neural circuits underlying emotion and cognition are dynamically coupled with the autonomic nervous system to shape interoception, and how disruptions in these integrated systems contribute to depression and anxiety.
With more than a decade of experience in neuromodulation, Dr. Austelle has worked across research and clinical settings using transcranial magnetic stimulation (TMS), accelerated protocols such as Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT), transcutaneous auricular vagus nerve stimulation (taVNS), and implanted vagus nerve stimulation (VNS). His research integrates clinical trials, neuroimaging, and psychophysiology to develop targeted, physiology-informed interventions.
Clinically, he specializes in treatment-resistant depression and anxiety disorders, applying evidence-based neuromodulation strategies for individuals who have not responded to standard treatments. -
Jeffrey Axelrod
Professor of Pathology
Current Research and Scholarly InterestsGenetic and cell biological analyses of signals controlling cell polarity and morphogenesis. Frizzled signaling and cytoskeletal organization.
-
Dan E. Azagury, MD, FACS
Associate Professor of Surgery (General Surgery)
Current Research and Scholarly Interests.
-
Muriel Babey
Assistant Professor of Medicine (Endocrinology)
BioMuriel Babey, M.D. is an Assistant Professor of Medicine in the Division of Endocrinology, Gerontology & Metabolism at Stanford University. She is a physician–scientist who specializes in metabolic bone disease and osteoporosis, with a focus on skeletal health during reproductive transitions and aging, as well as disorders of calcium and parathyroid metabolism.
Originally from Switzerland, Dr. Babey earned her medical degree in Switzerland and completed fellowship training in Endocrinology at the University of California, San Francisco. During her postdoctoral training in the laboratory of Holly Ingraham at UCSF, her work focused on identifying CCN3 as a maternal brain–derived osteoanabolic hormone critical for lactation, uncovering a previously unrecognized neuroendocrine axis regulating bone formation and marrow adiposity.
Dr. Babey directs a research program that integrates human cohort studies with mechanistic models to define endocrine pathways coordinating skeletal and metabolic resilience across reproductive transitions and aging. Her work centers on identifying secreted factors and interorgan communication networks that regulate bone health, with the goal of advancing translational strategies for osteoporosis and related metabolic diseases. Her research is supported by an NIH K08 award, and she is a recipient of the Endocrine Society Early Investigator Award and the ASBMR John Haddad Early Investigator Award. -
Rosa Bacchetta
Professor (Research) of Pediatrics (Stem Cell Transplantation)
Current Research and Scholarly InterestsIn the coming years, I plan to further determine the genetic and immunological basis of diseases with autoimmunity or immune dysregulation in children. I believe that much can still be learned from the in depth mechanistic studies of pediatric autoimmune diseases. Genomic analysis of the patients' samples has become possible which may provide a rapid indication of altered target molecules. I plan to implement robust functional studies to define the consequences of these genetic abnormalities and bridge them to the patient's clinical phenotype.
Understanding functional consequences of gene mutations in single case/family first and then validating the molecular and cellular defects in other patients with similar phenotypes, will anticipate and complement cellular and gene therapy strategies.
For further information please visit the Bacchetta Lab website:
http://med.stanford.edu/bacchettalab.html